Open original FDA record ↗Recall record
- FDA identifier
- Z-1098-2012
- Company in FDA record
- Accuray Incorporated
- FDA classification date
- Feb 23, 2012
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 17, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
An anomaly was discovered during internal regression testing, where the dose information is displayed incorrectly during treatment planning during a specific workflow using the optional 4D Ray Tracing dose calculation algorithm. As a result, it is possible that the dose calculation will display a lower dose than the intended dose prescribed for treatment delivery.
Source facts
- Action
- Accuray sent an "URGENT DEVICE CORRECTION" letter dated January 16, 2012 to all affected customers. The letter describes the product, problem, and the actions to be taken by the customers. The letter provides a work around to prevent the issue from happening. Contact Accuray Customer Support at 1-877-668-8667for questions regarding this notice.
- Initiated
- 2012-01-16
- Root cause
- Software design
- Terminated
- 2012-09-28
- Distribution
- Worldwide Distribution-USA (nationwide) and the countries of Korea, Hong Kong, China, Canada, Turkey, India, Russia, Italy, France, Belgium, Poland, Germany, Netherlands, United Kingdom, Spain, Greece, Saudi Arabia, Switzerland, Ukraine, Czech Republic, and Japan.
- Recall number
- Z-1098-2012
- Recall status
- Terminated
- CDRH record ID
- 107168
- FDA classified
- 2012-02-23
- Recall event number
- 61045